RAYDYMIX
LIVE

Serial Number

79338580

Owner

A. RAYMOND ET CIE

Attorney

JANET G RICCIUTI

Filing Date

Feb 16, 2022

Add to watchlist:

No watchlists yet
View on USPTO

RAYDYMIX Trademark

Serial Number: 79338580 • Registration: 7051260

RAYDYMIX is a trademark filed by A. RAYMOND ET CIE on February 16, 2022. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

A. RAYMOND ET CIE (47 trademarks)

TRAUNREUT D-83301 - , DE

Entity Type: 92

Trademark Details

Filing Date

February 16, 2022

Registration Date

May 16, 2023

Published for Opposition

February 28, 2023

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 12, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 19, 2023 FICS
FINAL DISPOSITION PROCESSED
Aug 19, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 16, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 16, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
May 16, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Feb 28, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 28, 2023 NPUB
PUBLISHED FOR OPPOSITION
Feb 28, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 8, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 8, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 8, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 20, 2023 CNSA
REFUSAL PROCESSED BY IB
Jan 4, 2023 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 2, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 2, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 2, 2023 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 12, 2022 RFCS
REFUSAL PROCESSED BY MPU
Dec 12, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 6, 2022 RFCR
NON-FINAL ACTION WRITTEN
Dec 5, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 1, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 26, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 22, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 21, 2022 REPR